CPhI, the Leading International Pharmaceutical Event Series, to Launch New North American Edition in May 2017

The launch of this event comes at an ideal time as the industry continues to experience massive growth. The North American generic pharmaceuticals market stands as the largest globally, valued at $71.8 billion, with expected growth of 3-6 percent annually between 2016 and 2020. On a larger scale, the global market for pharmaceutical contract research and manufacturing services (PCRAMS) is set to grow by an average of 13.6 percent each year through 2017, by which time it will be worth a staggering $136 billion.

"CPhI North America will provide an unrivalled opportunity to become a key stakeholder in a leading pharma landscape," said CPhI North America Portfolio Director, Robyn Duda. "With the projected growth of the pharma industry in this region, there isn't a better time to bring such an established pharmaceutical event to North America in 2017."

CPhI North America will bring the entire pharmaceutical value chain together at one time to serve as the platform for thought leadership, partnerships and innovation in the North American pharmaceutical industry. The event will offer exclusive networking and educational opportunities, including an onsite conference program hosted in partnership with CBI, the leading life science conference producer. The event will focus first and foremost on the buying and selling of pharmaceutical ingredients and API's. In addition to ingredients, conference verticals will include contract services, packaging, machinery/technology, finished dosage formulation and biopharmaceuticals.

Dedicated Show Floor Zones Will Deliver the Most Relevant Buyers

To serve the needs of the North American pharmaceutical supply chain the following brands, affiliated with CPhI Worldwide, will comprise the zoned show floor.

• CPhI North America will focus on pharmaceutical ingredients with exhibiting companies covering ingredients, APIs, excipients and more.
• ICSE will connect the pharmaceutical community with outsourcing solution providers.
• InnoPack will offer innovative and diverse drug delivery solutions to satisfy the changing way in which medication is packaged and delivered.
• FDF will bring every aspect of the finished dosage supply chain together, from Big Pharma and CMO, to out-licensing specialists, end product distributors, end user agents and home markets.

"It has been tremendous hearing firsthand the positive reaction from customers, associations and business partners alike regarding this new regional addition of the CPhI brand in North America," commented Rutger Oudejans, Brand Director, UBM EMEA, Pharma Portfolio, about the positive feedback from the industry. "The feedback reinforces this exciting launch as a key platform for doing business in the US pharma market and indeed the biggest pharmaceutical market in the world!"

To learn more about CPhI North America or to register your interest, visit: www.cphi.com/northamerica

The CPhI North America team will be hosting a preview event for prospective exhibitors and interested media on May 25, 2016 at the Pennsylvania Convention Center in Philadelphia, PA. Attendance is limited. To register your interest, please go to http://info.informex.com/rsvp.  

About CPhI
CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, China, India, Japan, Southeast Asia, Russia, Istanbul and South America co-located with ICSE for contract services, P-MEC for machinery, equipment & technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com and hosts a global community with news and analysis at PharmaEvolution.com. For more information visit: www.cphi.com.

UBM Americas
UBM Americas, a part of UBM plc, delivers events and marketing services in the fashion, technology, licensing, advanced manufacturing, automotive and powersports, healthcare, veterinary and pharmaceutical industries, among others. Through a range of aligned interactive environments, both physical and digital, UBM Americas increases business effectiveness for customers and audiences through meaningful experiences, knowledge and connections. The division also includes UBM Brazil's market leading events in construction, cargo transportation, logistics & international trade, and agricultural production; and UBM Mexico's, construction, advanced manufacturing and hospitality services shows. For more information, visit: www.ubmamericas.com.

Sources:

1. IMS Market Prognosis April 2015
2. Transparency Market Research – API/Contract Manufacturing
3. Transparency Market Research
4. IMS Health, Global Medicines in Use 2020    
5. IMS Health, Report Global spending on medicines in 2020

Photo - http://photos.prnewswire.com/prnh/20160413/354828
Logo - http://photos.prnewswire.com/prnh/20160413/354829LOGO

SOURCE CPhI

Related Links

http://www.cphi.com